1. Home
  2. ATMU vs ERAS Comparison

ATMU vs ERAS Comparison

Compare ATMU & ERAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Atmus Filtration Technologies Inc.

ATMU

Atmus Filtration Technologies Inc.

HOLD

Current Price

$48.49

Market Cap

5.0B

ML Signal

HOLD

Logo Erasca Inc.

ERAS

Erasca Inc.

HOLD

Current Price

$11.60

Market Cap

5.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATMU
ERAS
Founded
1958
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.0B
5.5B
IPO Year
2023
2021

Fundamental Metrics

Financial Performance
Metric
ATMU
ERAS
Price
$48.49
$11.60
Analyst Decision
Buy
Strong Buy
Analyst Count
4
12
Target Price
$58.25
$14.25
AVG Volume (30 Days)
1.1M
8.2M
Earning Date
05-01-2026
05-08-2026
Dividend Yield
0.36%
N/A
EPS Growth
12.61
36.23
EPS
0.59
N/A
Revenue
$1,764,300,000.00
N/A
Revenue This Year
$15.00
N/A
Revenue Next Year
$5.13
N/A
P/E Ratio
$82.96
N/A
Revenue Growth
5.67
N/A
52 Week Low
$34.58
$1.06
52 Week High
$66.50
$24.28

Technical Indicators

Market Signals
Indicator
ATMU
ERAS
Relative Strength Index (RSI) 32.56 45.04
Support Level $43.53 $9.80
Resistance Level $51.84 $16.14
Average True Range (ATR) 1.92 0.70
MACD -0.70 0.18
Stochastic Oscillator 13.83 92.17

Price Performance

Historical Comparison
ATMU
ERAS

About ATMU Atmus Filtration Technologies Inc.

Atmus Filtration Technologies Inc manufactures filtration products for on-highway commercial vehicles and off-highway agriculture, construction, mining, and power generation vehicles and equipment. The company designs and manufactures Developed filtration products, principally under the Fleetguard brand, that enable lower emissions and provide asset protection. It designs, manufactures, and sells filters, coolants, and chemical products. The company offers products including air filtration, coolants and chemicals, crankcase ventilation, fuel filtration, fuel cells, lube filtration, and others.

About ERAS Erasca Inc.

Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. Its focused RAS/MAPK pathway pipeline comprises modality-agnostic programs aligned with three therapeutic strategies of: targeting key upstream and downstream signaling nodes in the RAS/MAPK pathway; targeting RAS directly; and targeting escape routes that emerge in response to treatment. Its pipeline includes two clinical-stage programs (ERAS-0015, a pan-RAS molecular glue; and ERAS-4001, a pan-KRAS inhibitor), and ERAS-12, a discovery-stage program.

Share on Social Networks: